Detection of single nucleotide substitution by competitive allele-specific short oligonucleotide hybridization (CASSOH) with immunochromatographic strip

Human Mutation

Volumn 22, Issue 2, 2003, Pages 166-172

  Matsubara, Yoichi ^a   Kure, Shigeo ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ACADM; ALDH2; CYP2C19; GLDC; Glycogen storage disease type Ia; Mutation detection; SNP

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 2; CYTOCHROME P450 2C19; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE;

ALLELE; ANALYTIC METHOD; ARTICLE; CHROMATOGRAPHY; COLOR; COMPETITIVE ALLELE SPECIFIC SHORT OLIGONUCLEOTIDE HYBRIDIZATION; CONTROLLED STUDY; DNA DETERMINATION; DNA HYBRIDIZATION; ENZYME DEFICIENCY; FEASIBILITY STUDY; GENE AMPLIFICATION; GENE MUTATION; GENE PROBE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; GLYCOGEN STORAGE DISEASE TYPE 1; HUMAN; HYPERGLYCINEMIA; IMMUNOCHROMATOGRAPHIC STRIP; LABORATORY; MEDICAL TECHNOLOGY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; ROOM TEMPERATURE; SINGLE NUCLEOTIDE POLYMORPHISM; TECHNIQUE; TEST STRIP; TIME;

ALLELES; BINDING, COMPETITIVE; CHROMATOGRAPHY; DNA; FALSE POSITIVE REACTIONS; FEASIBILITY STUDIES; GENOTYPE; HUMANS; IMMUNOASSAY; MUTAGENESIS, INSERTIONAL; NUCLEIC ACID HYBRIDIZATION; NUCLEOTIDES; OLIGONUCLEOTIDE PROBES; OLIGONUCLEOTIDES; POINT MUTATION;

EID: 0042593083     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.10247     Document Type: Article

References (31)

1. Ando Y, Saka H, Ando M, Sawa T, Muro K, Ueoka H, Yokoyama A, Saitoh S, Shimokata K, Hasegawa Y. 2000. Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res 60:6921-6926.
2. Bonner TI, Brenner DJ, Neufeld BR, Britten RJ. 1973. Reduction in the rate of DNA reassociation by sequence divergence. J Mol Biol 81:123-135.
3. Collins FS. 1999. Medical and societal consequences of the human genome project. N Eng J Med 341:28-37.
4. Compton J. 1991. Nucleic acid sequence-based amplification. Nature 350:91-92.
5. Cotton RGH. 1997. Mutation detection. Oxford: Oxford University Press. p 1-23.
6. de Morais SM, Wilkinson GR, Blaisdell J, Nakamura K, Meyer UA, Goldstein JA. 1994. The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem 269:15419-15422.
7. Fakhrai-Rad H, Pourmand N, Ronaghi M. 2002. Pyrosequencing: an accurate detection platform for single nucleotide polymorphisms. Hum Mutat 19:479-485.
8. Fujii K, Matsubara Y, Akanuma J, Takahashi K, Kure S, Suzuki Y, Imaizumi M, Iinuma K, Sakatsume O, Rinaldo P, Narisawa K. 2000. Mutation detection by TaqMan-allele specific amplification: application to molecular diagnosis of glycogen storage disease type Ia and medium-chain acyl-CoA dehydrogenase deficiency. Hum Mutat 15:189-196.
9. Jonas V, Alden MJ, Curry JI, Kamisango K, Knott CA, Lankford R, Wolfe JM, Moore DF. 1993. Detection and identification of mycobacterium tuberculosis directly from sputum sediments by amplification of rRNA. J Clin Microbiol 31:2410-2416.
10. Kajihara S, Matsuhashi S, Yamamoto K, Kido K, Tsuji K, Tanae A, Fujiyama S, Itoh T, Tanigawa K, Uchida M, Setoguchi Y, Motomura M, Mizuta T, Sakai T 1995. Exon redefinition by a point mutation within exon 5 of the glucose-6-phosphatase gene is the major cause of glycogen storage disease type 1a in Japan. Am J Hum Genet 57:549-555.
11. Krawczak M, Ball EV, Fenton I, Stenson PD, Abeysinghe S, Thomas N, Cooper DN. 2000. Human gene mutation database: a biomedical information and research resource. Hum Mutat 15:45-51.
12. Krynetski EY, Evans WE. 1998. Pharmacogenetics of cancer therapy: getting personal. Am J Hum Genet 63:11-16.
13. Kure S, Takayanagi M, Narisawa K, Tada K, Leisti J. 1992. Identification of a common mutation in Finnish patients with nonketotic hyperglycinemia. J Clin Invest 90:160-164.
14. Livak KJ. 1999. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14:143-149.
15. Lizardi PM, Huang X, Zhu Z, Bray-Ward P, Thomas DC, Ward DC. 1998. Mutation detection and single-molecule counting using isothermal rolling-circle amplification. Nat Genet 19:225-232.
16. Lyamichev V, Mast AL, Hall JG, Prudent JR, Kaiser MW, Takova T, Kwiatkowski RW, Sander TJ, de Arruda M, Arco DA, Neri BP, Brow MA. 1999. Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nat Biotechnol 17:292-296.
17. Matsubara Y, Narisawa K, Miyabayashi S, Tada K, Coates PM, Bachmann C, Elsas LJ 2nd, Pollitt RJ, Rhead WJ, Roe CR. 1990. Identification of a common mutation in patients with medium-chain acyl-CoA dehydrogenase deficiency. Biochem Biophys Res Commun 171:498-505.
18. Meyer UA. 2000. Pharmacogenetics and adverse drug reactions. Lancet 356:1667-1671.
19. Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T 2000. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 28:E63.
20. Nozari G, Rahbar S, Wallace RB. 1986. Discrimination among the transcripts of the allelic human beta-globin genes beta A, beta S and beta C using oligodeoxynucleotide hybridization probes. Gene 43:23-28.
21. Oka T, Matsunaga H, Tokunaga K, Mitsunaga S, Juji T, Yamane A. 1994. A simple method for detecting single base substitutions and its application to HLA-DPB1 typing. Nucleic Acids Res 22:1541-1547.
22. Pastinen T, Raitio M, Lindroos K, Tainola P, Peltonen L, Syvanen AC. 2000. A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays. Genome Res 10:1031-1042.
23. Pirmohamed M, Park BK. 2001. Genetic susceptibility to adverse drug reactions. Trends Pharmacol Sci 22:298-305.
24. Pischke S, Buttner DW, Liebau E, Fischer P. 2002. An internal control for the detection of Onchocerca volvulus DNA by PCR-ELISA and rapid detection of specific PCR products by DNA detection test strips. Trop Med Int Health 7:526-531.
25. Pusch W, Wurmbach JH, Thiele H, Kostrzewa M. 2002. MALDI-TOF mass spectrometry-based SNP genotyping. Pharmacogenomics 3:537-548.
26. Roe CR, Coates PM. 1995. Mitochondrial fatty acid oxidation disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease, 7th ed. New York: McGraw-Hill. p 1501-1533.
27. Saiki RK, Erlich HA. 1998. Detection of mutations by hybridization with sequence-specific oligonucleotide probes. In: Cotton RGH, Edkins E, Forrest S, editors. Mutation detection. Oxford: Oxford University Press. p 113-129.
28. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press. p 11.1-11.61.
29. Terouanne B, Balaguer P, Boussioux AM, Nicolas JC. 1992. Quantitative and qualitative analysis of amplified DNA sequences by a competitive hybridization assay. Anal Biochem 205:193-199.
30. Wetmur JG. 1991. DNA probes: applications of the principles of nucleic acid hybridization. Crit Rev Biochem Mol Biol 26:227-259.
31. Yoshida A, Huang IY, Ikawa M. 1984. Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in Orientals. Proc Natl Acad Sci USA 81:258-261.